title: From Th1 to Th2: diabetes immunotherapy shifts gears.
authors.forename: M
authors.initials: M
authors.lastname: Solimena
authors.forename: P
authors.initials: P
authors.lastname: De Camilli
mesh_terms: D000818:Animals; D001324:Autoantigens / Q000627:therapeutic use*; D003922:Diabetes Mellitus, Type 1 / Q000628:therapy*; D004195:Disease Models, Animal; D005968:Glutamate Decarboxylase / Q000627:therapeutic use*; D007167:Immunotherapy; D051379:Mice; D016688:Mice, Inbred NOD; D018417:Th1 Cells / Q000276:immunology*; D018418:Th2 Cells / Q000276:immunology*
chemical_list: D001324:Autoantigens; D005968:Glutamate Decarboxylase